Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 8.93
Day High 9.98
Open:9.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Aphria Inc and its subsidiaries produce and sell medical marijuana. Its products include Capsules, Oral solutions, and Vaporizers. The company's operations are based in Leamington, Ontario. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale channels.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Cannabis Comes to the Fore as Tobacco and Alcohol Use Slide
PR Newswire - Fri May 24, 8:00AM CDT
PR Newswire - CMTX
Fri May 24, 8:00AM CDT
The widespread growth of the cannabis industry has caught the interest of numerous public and private sectors. Currently, the cannabis industry is an emerging global marketplace which has witnessed immense growth throughout recent years. The exponential growth of the industry is largely due to the ongoing global legalization efforts which make it hard for companies to ignore the plant. Particularly, companies involved in the tobacco and beverage industry have taken a keen interest as the two sectors have poured investments into cannabis-based companies or even launched their own cannabis operations. The biggest factor as to why the tobacco and beverage industries are investing in cannabis is that many are witnessing their primary revenue drivers decline. For instance, the Centers for Disease Control and Prevention reported that cigarette smoking among U.S. adults declined from 20.9% in 2005 to just 15.5% in 2016. Moreover, The Wall Street Journal's industry tracker, IWSR, highlighted that U.S. alcohol volume dropped by 0.8% in the past year, a slight increase on the 0.7% decline in 2017. Conversely, the cannabis industry is witnessing its user base and support increase each year and public opinion has consistently proven that most Americans support the legalization of cannabis. According to a survey by Gallup, approximately 60% of Americans support the legalization, which is significantly up from just 44% in 2014. While cannabis is still illegal in most countries, its growing adoption highlights the profound shift the industry is currently undergoing. According to data compiled by BCC Research, the North American legal cannabis market was valued at USD 10.7 Billion in 2018. By 2023, the market is expected to reach USD 25.5 Billion while exhibiting a CAGR of 18.9% during the forecast period from 2018 to 2023. Canopy Rivers Inc. (OTC: CNPOF) (TSX-V: RIV), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Aphria Inc. (NYSE: APHA) (TSX: APHA), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX-V: OGI)
Canna Cabana Granted Membership into Canadian Franchise Association
- CNW Group - CND - Fri May 17, 6:30AM CDT
CNW Group - CND - CMTX
Fri May 17, 6:30AM CDT
/NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./
International Regions are Warming up to the CBD and Cannabis Industry
PR Newswire - Thu May 16, 8:00AM CDT
PR Newswire - CMTX
Thu May 16, 8:00AM CDT
In recent years, the cannabis industry has witnessed immense support from countries across the world. Numerous national governments have their own unique perspective regarding the plant, however, most still have not moved to legalize cannabis because of the stigma surrounding its psychoactive nature. Nonetheless, cannabis has already tapped into several of the largest global markets. For instance, Canada became the first and only G-7 nation to legalize cannabis entirely in late 2018. Meanwhile, among the other G-7 nations, France, Germany, Italy, the United Kingdom and the U.S. have all adopted partial or full medical cannabis legislation. The only G-7 nation to not have adopted any form of cannabis legislation is currently Japan. Overall, many Asian countries enforce stricter regulations, which result in severe consequences if violated. As such, cannabis companies have not had much luck tapping into the Asian markets. However, South Korea and Thailand are two Asian countries that decided to take steps forward and dive into the cannabis industry. South Korea's medical cannabis program launched in early March and paved the way for select THC and CBD-based medication imports. In particular, Canopy Growth Corporation is among the several Canadian multinational firms looking to enter the South Korean market. Similarly, Thailand has moved to legalize medical cannabis, with many expecting the legislation to be implemented next year after Thailand's military-appointed National Legislative Assembly voted 166 to 0 in favor of legalizing medical cannabis. The profound movement stirring throughout Asia further highlights the impact that cannabis is making on a global scale. Moreover, ongoing international legalization efforts are expected to accelerate and further bolster the market in the near future. According to data compiled by MarketsandMarkets research, the cannabis market was valued at USD 10.3 Billion in 2018. By 2023, the market is expected to reach USD 39.4 Billion while registering a CAGR of 30.7% during the forecast period. Canopy Rivers Inc. (OTC: CNPOF) (TSX-V: RIV), Anheuser-Busch InBev SA/NV (NYSE: BUD), Aphria Inc. (NYSE: APHA) (TSX: APHA), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), New Age Beverages Corporation (NASDAQ: NBEV)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 8.60 +14.88% increase
on 05/23/19
Period Open:10.58
Price movement based on the high, low and last over the given period.
10.55 -6.35% decrease
on 04/25/19
-0.70 (-6.62%) decrease
since 04/24/19
3-Month 8.60 +14.88% increase
on 05/23/19
Period Open:13.31
Price movement based on the high, low and last over the given period.
14.21 -30.47% decrease
on 03/04/19
-3.43 (-25.77%) decrease
since 02/22/19
52-Week 4.76 +107.56% increase
on 12/05/18
Period Open:12.20
Price movement based on the high, low and last over the given period.
22.00 -55.09% decrease
on 09/12/18
-2.32 (-19.02%) decrease
since 05/24/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).